BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16395974)

  • 1. Clinical PET/CT imaging: promises and misconceptions.
    Czernin J; Auerbach MA
    Nuklearmedizin; 2005; 44 Suppl 1():S18-23. PubMed ID: 16395974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.
    Weber WA; Grosu AL; Czernin J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):160-70. PubMed ID: 18253106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography/computed tomography.
    Townsend DW
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IV. Hungarian PET/CT Multidisciplinary Consensus Conference -- position statement].
    Katalin B; István S; Miklós K;
    Magy Onkol; 2011 Jun; 55(2):117-27. PubMed ID: 21780330
    [No Abstract]   [Full Text] [Related]  

  • 6. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography (PET)--current state of the art and future perspectives].
    von Schulthess GK;
    Praxis (Bern 1994); 2005 Aug; 94(35):1331-7. PubMed ID: 16171004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET scan-CT correlation: what the chest radiologist needs to know.
    Kuhlman JE; Perlman SB; Weigel T; Collins J; Yandow D; Broderick LS
    Curr Probl Diagn Radiol; 2004; 33(4):171-88. PubMed ID: 15306761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of PET and PET/CT in pediatric malignancies.
    Kumar R; Shandal V; Shamim SA; Halanaik D; Malhotra A
    Expert Rev Anticancer Ther; 2010 May; 10(5):755-68. PubMed ID: 20470007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated PET-CT: evidence-based review of oncology indications.
    Sachelarie I; Kerr K; Ghesani M; Blum RH
    Oncology (Williston Park); 2005 Apr; 19(4):481-90; discussion 490-2, 495-6. PubMed ID: 15934517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT: nuclear medicine imaging in the future.
    Riklund KA
    Radiat Prot Dosimetry; 2010; 139(1-3):8-11. PubMed ID: 20200102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Has the development of PET come to an end with PET-CT?].
    Bockisch A; Rosenbaum S
    Rofo; 2005 Jan; 177(1):14-6. PubMed ID: 15657815
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
    Czernin J; Allen-Auerbach M; Schelbert HR
    J Nucl Med; 2007 Jan; 48 Suppl 1():78S-88S. PubMed ID: 17204723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rise and fall of PET and PET/CT: a German perspective.
    Mohnike W
    Nuklearmedizin; 2005; 44 Suppl 1():S58-60. PubMed ID: 16395981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-modality PET/CT tomography for clinical oncology.
    Beyer T; Townsend DW; Blodgett TM
    Q J Nucl Med; 2002 Mar; 46(1):24-34. PubMed ID: 12072843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
    Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
    J Nucl Med Technol; 2010 Mar; 38(1):6-17. PubMed ID: 20197541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application value of MRI combined with positron emission tomography (PET)/CT in diagnosis and preoperative staging of tongue squamous cell carcinoma.
    Chen W; Zhang C; Zhang S; Liang L; Zhang B; Liu C; Zhang Z; Liang C
    J Med Imaging Radiat Oncol; 2015 Apr; 59(2):170-8. PubMed ID: 25753588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET and PET-CT. State of the art and future prospects.
    Fanti S; Franchi R; Battista G; Monetti N; Canini R
    Radiol Med; 2005; 110(1-2):1-15. PubMed ID: 16163136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.